Dr. Charles Keller was a practicing pediatric oncologist who, after witnessing the limited options of his patients, sought out a new opportunity and founded his own research facility. Dr. Keller launched the Children’s Cancer Therapy Development Institute (cc-TDI) and has since spent decades devoted to the research of rare, aggressive and difficult-to-treat pediatric cancers.
Our Story
Along the way, Dr. Keller has personally helped countless families, including those who were told their child had no remaining treatment options.
Dr. Keller has compiled a massive amount of experience, preclinical data, research and published works.
Dr. Keller and a team of like-minded individuals launched Artisan Biopharma with the aim of using the knowledge and experience of cc—TDI to disrupt the status quo of the pediatric cancer drug development process. Simply said, the Artisan team will curate and accelerate clinical trials to get better treatment options to our children, faster.